The Pacing You Choose Is Worth More Than IRR Can See

Same managers, same exposure, different outcome

Two private-equity programs target the same exposure with the same funds and end years apart in value. The difference is rarely selection or sizing. It is pacing — the schedule on which capital is committed across vintages — and most evaluation frameworks cannot see it at all.

Pacing is a position on a frontier, not a calendar detail

Extend the commitment problem from a single decision to a multi-year, multi-fund program and a frontier appears. At one end, smooth, even pacing: the liquidity buffer the program needs stays low, but so does the capital actually put to work, and with it the terminal value. At the other end, concentrated pacing: the program deploys more and earns more — while operating close to the liquidity limit, where a single stressed period can force a shortfall. Between them is a genuine trade-off:

• Even pacing → lower buffer requirement, lower terminal value (safe, leaves money on the table).
• Concentrated pacing → higher terminal value, thinner buffer (more earned, real funding risk).

There is no free position on this frontier — only a trade-off to be chosen deliberately, against the institution's own liquidity tolerance.

The cost that hides from IRR

The decisive point: that choice is economically material, and it compounds. Run the same program through a full multi-period cash-flow simulation under a deliberately optimized pacing policy versus a naive even-pacing one, and the two diverge in value created — modestly in any single year, but the gap widens across the life of the program as differences in deployment, distribution, and reinvestment accumulate. What looks like a small per-dollar edge early becomes a substantial sum by the time a large institutional program matures.

And here is the trap: because the difference shows up in the timing and total of cash, not the rate of return, an IRR comparison can rate the optimized and the naive programs as effectively identical. A metric that can't distinguish a materially better pacing policy is the wrong instrument to govern it by. Pacing deserves to be treated as a first-order policy choice — with a real, compounding cost of getting it wrong — not a scheduling detail left to a fixed annual multiple.

This trade-off is not asserted — it is what the firm's multi-period cash-flow simulation engine produces when a program is modeled at the asset-class and fund level. That engine, and the proprietary research and decade-plus of production portfolio optimization behind it, develop the full profit–liquidity frontier; available on request.